RESHMA ARAKKAL: Open Payments
NPI 1205698990 · LEHIGH ACRES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,171 in 60 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $528 · 2025 $1,171
Food & beverage: $1,171
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $239 |
| Novo Nordisk Inc | 12 | $218 |
| ABBVIE INC. | 8 | $144 |
| Novartis Pharmaceuticals Corporation | 5 | $92 |
| Lilly USA, LLC | 3 | $69 |
| Astellas Pharma US Inc | 3 | $65 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Exact Sciences Corporation | 2 | $56 |
| PFIZER INC. | 3 | $48 |
| Amgen Inc. | 2 | $43 |
Products named: TRELEGY ELLIPTA, LEQVIO, Ozempic, VRAYLAR, JARDIANCE, Veozah, Auvelity, Cologuard Collection Kit.
Industry payments across FL — which companies pay providers there.
